Finanzen von Syra Health Corp (SYRA)SYRASyra Health Corp

Evaluating the bottom line, Syra Health Corp maintains a gross margin of 22.33%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -25.00%, while the net margin is -25.14%. These profitability ratios, combined with a Return on Equity (ROE) of -109.09%, provide a clear picture of how effectively SYRA converts its operational activities into shareholder value.

In the context of the broader market, SYRA competes directly with industry leaders such as PET and JOB. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, SYRA's gross margin of 22.33% stands against PET's 87.85% and JOB's 39.56%. Such benchmarking helps identify whether Syra Health Corp is trading at a premium or discount relative to its financial performance.